ORION CORP.

ORION CORP.

KKRX:271560
111,300.00
KRW
-1,300.00
(-1.15%)
10,782.76EPS
12.44P/E
5.21TMarket Cap
Feb 11Next Earn
ORION CORP.
KRX:271560
(Korea Stock Exchange)

Recent

price

111,300.00

P/E

ratio

12.44

div

yld

0.17%

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
27,150.16
48,748.24
51,187.92
56,406.65
59,585.72
72,689.55
73,673.71
78,532.71
84,306.99
90,506.49
Revenue per Share
1,912
3,538
5,454
6,769
6,519
9,926
9,528
13,271
9,682
10,604.89
Basic EPS, GAAP
2,569.67
6,719.91
5,528.75
7,671.37
6,505.81
11,519.01
6,783.56
13,368.09
9,892.18
10,216.69
Free Cash Flow per Basic Share
- -
599.81
599.89
599.96
749.95
750.02
949.96
1,422.66
2,686.56
186.48
Dividend per Share
33,097.78
35,559.57
41,049.54
46,294.25
55,935.04
64,605.64
72,413.04
87,815.38
96,351.64
102,850.44
Book Value per Share
31,772.59
34,252.41
39,665.73
44,890.3
54,484.37
63,213.18
71,053.01
86,041.48
94,069.3
100,347.18
Tangible Book Value per Share
40
40
40
40
40
40
40
40
40
40
Basic Weighted Avg Shares
1,073,283
1,926,948
2,023,296
2,229,820
2,355,500
2,873,247
2,912,358
3,104,339
3,332,443
3,577,445
Sales/Revenue/Turnover
10.01
14.64
16.19
16.87
15.83
16.24
16.91
17.51
16.75
16.87
Operating Margin (%)
65,803
117,818
132,192
138,964
149,747
161,654
157,192
160,451
164,616
171,771
Depreciation Expense
75,584
139,852
215,579
267,586
257,704
392,351
376,647
524,593
382,705
419,179
Net Income, GAAP
27.01
48.03
28.44
30.9
30.44
18.17
25.97
22.97
28.53
29.4
Effective Tax Rate (%)
7.04
7.26
10.65
12
10.94
13.66
12.93
16.9
11.48
11.72
Profit Margin (%)
-65,519
68,914
131,860
452,040
624,320
914,253
1,229,285
1,109,766
1,368,837
1,446,492
Working Capital
329,446
279,612
176,887
246,129
83,352
13,781
14,296
25,790
21,820
122,326
LT Debt
1,344,904
1,444,542
1,667,543
1,897,508
2,292,550
2,639,229
2,955,477
3,574,046
3,912,207
4,180,682
Total Equity
- -
7.58
11.99
12.43
10.89
14.12
12.42
12.45
10.37
10.56
Return on Invested Capital (%)
- -
7.61
11.33
12.86
10.9
14.7
12.92
15.66
10.19
10.63
Return on Capital (%)
- -
10.31
14.24
15.5
12.75
16.47
13.91
16.57
10.51
11.09
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
13,696
13,936
27,223
LT Borrowings
- -
- -
- -
LT Finance Leases
21,820
20,566
122,326
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
40
40
40
Market Capitalization
4,178,193
5,059,685
5,213,847

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,867,027
1,993,616
1,951,041
Cash, Cash Equivalents & STI
1,302,467
1,435,722
1,366,204
Accounts Receivable, Net
181,999
177,540
182,522
Inventories
321,415
305,371
312,604
Total Current Liabilities
498,191
587,680
504,549
Payables & Accruals
- -
- -
- -
ST Debt
13,696
13,936
27,223
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
15.66%
9.46%
Free Cash Flow
- -
18.36%
-26%
Net Income, GAAP
- -
11.36%
-27.05%
Sales/Revenue/Turnover
- -
8.58%
7.35%
Total Cash Common Dividend
- -
- -
88.83%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
748,391
719,264
774,870
861,814
3,104,339
2025
801,773
777,166
828,922
924,582
3,332,443
2026
930,355
893,586
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,374
1,973
2,522
6,402.45
13,271
2025
2,639
1,767
2,597
2,678.58
9,682
2026
3,149.21
2,180
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
172.68
1,422.66
2025
- -
- -
- -
186.47
2,686.56
2026
- -
- -
- -
- -
- -
Business
ORION Corp., founded in 1956 and headquartered in Seoul, South Korea, is a global food and healthcare company specializing in the manufacture and sale of a wide range of confectionery products. Its core product portfolio includes pies, snacks, biscuits, candies, jellies, gums, chocolates, protein drinks and powders, bars, granola products, and mineral water marketed under various brands such as Orion Power, Dr.You, Market O, Market O Nature, Chocopie House, and Jeju yongamsoo. The company operates manufacturing facilities domestically in South Korea and internationally in China, Russia, Vietnam, India, and the United States. ORION also engages in food and beverage production, agricultural product processing, pulp and paper manufacturing, in vitro diagnostics for early cancer detection, and vaccine production. Recent major developments include its revised guidance for fiscal year 2025 reflecting a milestone payment of EUR 180 million from its partner Bayer related to sales of the drug Nubeqa, boosting its expected net sales to EUR 1.82-1.9 billion and operating profit to EUR 590-670 million. ORION continues to expand its global footprint through product innovation and strategic alliances, including broadening its beverage and bio-business segments. The company employs approximately 1,400 full-time staff and maintains an international presence targeting consumer and health markets worldwide. ORION remains committed to growth through both traditional confectionery markets and new ventures in healthcare and nutrition products, leveraging its diverse brand portfolio and extensive production capabilities across Asia and beyond.